Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
More about the company